Reply to Eschenauer et al

Схожие документы

• Reply to O’Riordan et al
  по: McKinnell, James A., et al.
  Опубликовано: (2015)
• Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy
  по: Goldstein, Ellie J. C., et al.
  Опубликовано: (2014)
• Reply to Kalil et al., “Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?”
  по: Sakoulas, George, et al.
  Опубликовано: (2019)
• Reply to L.H. Einhorn et al
  по: McHugh, Deaglan, et al.
  Опубликовано: (2020)
• Reply to Blot et al. and to Inoue et al.
  по: McElvaney, Oliver J., et al.
  Опубликовано: (2021)